U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277010) titled 'AI Wound Alert & Home Management for Recurrent DFU' on Nov. 30.
Brief Summary: Diabetes is one of the major chronic diseases, and diabetic foot ulcer (DFU) is a significant adverse prognosis of diabetes. The recurrence of DFU after healing involves multiple risk factors, such as changes in foot loading patterns, patient compliance, family care capacity, blood glucose monitoring, the degree of ischemia, and control of systemic diseases. Early identification of signs of DFU recurrence and timely follow-up interventions are crucial for improving prognosis, reducing disability rates, and lowering healthcare costs. However, traditional f...